Cargando…
P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430161/ http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9 |
_version_ | 1785090889711878144 |
---|---|
author | Salmanton-García, Jon Marchesi, Francesco Weinbergerová, Barbora Buquicchio, Caterina Čolović, Natasa Praet, Jens VAN Koehler, Philipp Falces-Romero, Iker Farina, Francesca Itri, Federico Romano, Alessandra Pagano, Livio Cornely, Oliver A. |
author_facet | Salmanton-García, Jon Marchesi, Francesco Weinbergerová, Barbora Buquicchio, Caterina Čolović, Natasa Praet, Jens VAN Koehler, Philipp Falces-Romero, Iker Farina, Francesca Itri, Federico Romano, Alessandra Pagano, Livio Cornely, Oliver A. |
author_sort | Salmanton-García, Jon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104301612023-08-17 P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY Salmanton-García, Jon Marchesi, Francesco Weinbergerová, Barbora Buquicchio, Caterina Čolović, Natasa Praet, Jens VAN Koehler, Philipp Falces-Romero, Iker Farina, Francesca Itri, Federico Romano, Alessandra Pagano, Livio Cornely, Oliver A. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430161/ http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Salmanton-García, Jon Marchesi, Francesco Weinbergerová, Barbora Buquicchio, Caterina Čolović, Natasa Praet, Jens VAN Koehler, Philipp Falces-Romero, Iker Farina, Francesca Itri, Federico Romano, Alessandra Pagano, Livio Cornely, Oliver A. P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title | P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title_full | P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title_fullStr | P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title_full_unstemmed | P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title_short | P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY |
title_sort | p1514: molnupiravir compared to nirmatrelvir/ritonavir for covid-19 in high-risk patients with haematological malignancy in europe. a matched-paired analysis from the epicovideha registry |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430161/ http://dx.doi.org/10.1097/01.HS9.0000972936.16284.b9 |
work_keys_str_mv | AT salmantongarciajon p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT marchesifrancesco p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT weinbergerovabarbora p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT buquicchiocaterina p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT colovicnatasa p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT praetjensvan p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT koehlerphilipp p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT falcesromeroiker p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT farinafrancesca p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT itrifederico p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT romanoalessandra p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT paganolivio p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry AT cornelyolivera p1514molnupiravircomparedtonirmatrelvirritonavirforcovid19inhighriskpatientswithhaematologicalmalignancyineuropeamatchedpairedanalysisfromtheepicovideharegistry |